Home
About Us
Help and Support
Subscribe
Company Analyst
Financial Analyst
Pipeline Analyst
Archives
Tools
Log In
Print this
MK-8742
print preview
bookmark
share with colleague
General Information
Company
Merck & Co. Inc.
Description
Oral NS5A inhibitor
Molecular Target
HCV NS5A protein
Mechanism of Action
HCV non-structural protein 5A inhibitor
Latest Stage of Development
Phase II
Indication
Hepatitis C virus (HCV)
Partner
Product Summary: Number of Indications in each Phase of Development by Disease Category
More
Product Details
Archive Items are loading
Set Email Alert
dummy